Abstract
Photodynamic therapy (PDT), in which stained cells are damaged by light in the presence of oxygen, is now widely used for tumor destruction. Photogenerated singlet oxygen and reactive oxygen species cause oxidative stress and cell death. The potential ROS sensors and following intracellular processes leading to cell death are considered. The cell death mode (necrosis or apoptosis) is shown to be controlled not only by PDT parameters (irradiation intensity, intracellular photosensitizer localization and its concentration) but also by signal transduction processes. Calcium and adenylate cyclase signaling pathways, receptor tyrosine kinases, MAP kinases, phosphatidylinositol 3-kinase pathway, various protein kinases and phosphatases, transcription factors, ceramide, NO, the plasma membrane, mitochondria and endoplasmic reticulum are involved in the cell response to photodynamic injury and following death. Combination of PDT and pharmacological modulators of signaling pathways can either enhance injury of malignant cells, or protect surrounding normal cells.
Keywords: Cell death, apoptosis, necrosis, signaling pathways, photodynamic therapy
Current Signal Transduction Therapy
Title: Signal Transduction and Photodynamic Therapy
Volume: 3 Issue: 1
Author(s): Anatoly B. Uzdensky
Affiliation:
Keywords: Cell death, apoptosis, necrosis, signaling pathways, photodynamic therapy
Abstract: Photodynamic therapy (PDT), in which stained cells are damaged by light in the presence of oxygen, is now widely used for tumor destruction. Photogenerated singlet oxygen and reactive oxygen species cause oxidative stress and cell death. The potential ROS sensors and following intracellular processes leading to cell death are considered. The cell death mode (necrosis or apoptosis) is shown to be controlled not only by PDT parameters (irradiation intensity, intracellular photosensitizer localization and its concentration) but also by signal transduction processes. Calcium and adenylate cyclase signaling pathways, receptor tyrosine kinases, MAP kinases, phosphatidylinositol 3-kinase pathway, various protein kinases and phosphatases, transcription factors, ceramide, NO, the plasma membrane, mitochondria and endoplasmic reticulum are involved in the cell response to photodynamic injury and following death. Combination of PDT and pharmacological modulators of signaling pathways can either enhance injury of malignant cells, or protect surrounding normal cells.
Export Options
About this article
Cite this article as:
Uzdensky B. Anatoly, Signal Transduction and Photodynamic Therapy, Current Signal Transduction Therapy 2008; 3 (1) . https://dx.doi.org/10.2174/157436208783334277
DOI https://dx.doi.org/10.2174/157436208783334277 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synergistic Approaches to Clinical Oncology Biomarker Discovery
Current Topics in Medicinal Chemistry Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis
Current Pharmaceutical Biotechnology Plant Polyphenols and Tumors: From Mechanisms to Therapies, Prevention, and Protection Against Toxicity of Anti-Cancer Treatments
Current Medicinal Chemistry iPSCs Derived from Malignant Tumor Cells: Potential Application for Cancer Research
Current Stem Cell Research & Therapy Blockade of Insulin-Like Growth Factor Type-1 Receptor with Cixutumumab (IMC-A12): A Novel Approach to Treatment for Multiple Cancers
Current Drug Targets Recent Advancements in 1,4-Disubstituted 1H-1,2,3-Triazoles as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Potential Therapeutic Targets for Steroid-Resistant Asthma
Current Drug Targets Hepatocyte Growth Factor and Macrophage-stimulating Protein “Hinge” Analogs to Treat Pancreatic Cancer
Current Cancer Drug Targets Editorial (Thematic Issue: Harmful and Beneficial Effect of Aspirin on Gastrointestinal Tract)
Current Pharmaceutical Design MiR-147: Functions and Implications in Inflammation and Diseases
MicroRNA Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Current Cancer Therapy Reviews Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues
Anti-Cancer Agents in Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update
Current Pharmaceutical Design Therapeutic Use of Heat Shock Protein 70
Recent Patents on DNA & Gene Sequences Calpain-Associated Proteolytic Regulation of the Stromal Microenvironment in Cancer
Current Pharmaceutical Design